204 related articles for article (PubMed ID: 34130018)
1. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer?
Kemper M; Molwitz I; Krause L; Reeh M; Burdelski C; Kluge S; Yamamura J; Izbicki JR; de Heer G
Clin Nutr; 2021 Jun; 40(6):3729-3740. PubMed ID: 34130018
[TBL] [Abstract][Full Text] [Related]
2. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
[TBL] [Abstract][Full Text] [Related]
4. Importance of computed tomography muscle quality and continuous versus cut-off-based sarcopenia detection in major hepatic surgery.
Molwitz I; Kemper M; Krause L; Adam G; Izbicki JR; Burdelski C; de Heer G; Gerdes L; Yamamura J; Li J
Ann Transl Med; 2022 Sep; 10(18):955. PubMed ID: 36267707
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
[TBL] [Abstract][Full Text] [Related]
6. The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer.
Nambara M; Miki Y; Tamura T; Yoshii M; Toyokawa T; Tanaka H; Lee S; Muguruma K; Shibata T; Ohira M
World J Surg; 2021 Oct; 45(10):3108-3118. PubMed ID: 34189621
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
[TBL] [Abstract][Full Text] [Related]
9. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
Tamandl D; Paireder M; Asari R; Baltzer PA; Schoppmann SF; Ba-Ssalamah A
Eur Radiol; 2016 May; 26(5):1359-67. PubMed ID: 26334504
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer.
Nishigori T; Okabe H; Tanaka E; Tsunoda S; Hisamori S; Sakai Y
J Surg Oncol; 2016 May; 113(6):678-84. PubMed ID: 26936808
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer.
Grotenhuis BA; Shapiro J; van Adrichem S; de Vries M; Koek M; Wijnhoven BP; van Lanschot JJ
World J Surg; 2016 Nov; 40(11):2698-2704. PubMed ID: 27272482
[TBL] [Abstract][Full Text] [Related]
13. Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study.
Makiura D; Ono R; Inoue J; Kashiwa M; Oshikiri T; Nakamura T; Kakeji Y; Sakai Y; Miura Y
J Geriatr Oncol; 2016 Nov; 7(6):430-436. PubMed ID: 27452909
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
15. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: A comparison with the malnutrition screening tool.
van der Kroft G; Bours DMJL; Janssen-Heijnen DM; van Berlo DCLH; Konsten DJLM
Clin Nutr ESPEN; 2018 Apr; 24():114-119. PubMed ID: 29576348
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma.
Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30809629
[TBL] [Abstract][Full Text] [Related]
17. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Masseter Muscle Sarcopenia Predicts Mortality in Patients With Oesophageal Cancer.
Kamada T; Ohdaira H; Ito E; Fuse Y; Takahashi J; Nakashima K; Nakaseko Y; Yoshida M; Eto K; Suzuki Y
Anticancer Res; 2022 Jan; 42(1):301-310. PubMed ID: 34969738
[TBL] [Abstract][Full Text] [Related]
19. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]